Treating Blood Cancers

Treating Blood Cancers

LLS Podcast Series for Professionals

Episodes

November 16, 2022 27 min

Daphne Friedman, MD, Durham VA Health Care System, Durham, NC

Recorded on October 20, 2022


Daphne Friedman, MD
Staff Oncologist, Durham VA Health Care System
Associate Professor, Duke University School of Medicine
Durham, NC In Part II of Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia, Dr. Daphne Friedman, from the Durham VA Health Care System in North Carolina, discusses the impo...

Mark as Played

Eytan M. Stein, MD, Memorial Sloan Kettering Cancer Center, New York, NY

Recorded on October 7, 2022


Eytan M. Stein, MD
Chief, Leukemia Service
Director, Program for Drug Development in Leukemia
Associate Attending Physician
Leukemia Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY

Dr. Eytan Stein, from Memorial Sloan Kettering Cancer Center, joins us to reflect o...

Mark as Played

Saad Z. Usmani, MD, MBA, FACP, Memorial Sloan Kettering Cancer Center, New York, NY

Recorded on September 30, 2022


Saad Z. Usmani, MD, MBA, FACP
Hematologic Oncologist
Chief, Myeloma Service
Memorial Sloan Kettering Cancer Center
New York, NY

Join us for this special episode, recorded live from the Tenth Annual Meeting of the Society of Hematologic Oncology in Houston, TX! Guest host and conference atten...

Mark as Played
September 20, 2022 35 min

Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX

Recorded on September 6, 2022


Naveen Pemmaraju, MD
Associate Professor
Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

Join us as Dr. Naveen Pemmaraju from MD Anderson Cancer Center, returns to discuss blastic plasmacytoid dendritic cell neoplasms (BPDCN...

Mark as Played

Jason Gotlib, MD, Stanford University School of Medicine, Palo Alto, CA

Recorded on July 19, 2022


Jason Gotlib, MD
Professor of Medicine in the Division of Hematology
Stanford Cancer Institute
Stanford University School of Medicine
Palo Alto, CA

Mastocytosis is a rare and complex disease. In this special episode, Dr. Jason Gotlib from the Stanford University School of Medicine in Palo Alto, CA, discus...

Mark as Played

Rafael Fonseca, MD, Mayo Clinic, Phoenix, AZ

Recorded on June 30, 2022


Rafael Fonseca, MD,
Chief Innovation Officer
Getz Family Professor of Cancer
Mayo Clinic
Phoenix, AZ

In this episode, Dr. Rafael Fonseca, from the Mayo Clinic in Arizona, joins Dr. Ken Miller to breakdown the complex and complicated nature of genomics and molecular profiling. He discusses the role of molecular profiling in treating ...

Mark as Played

Kevin C. Oeffinger, MD, FASCO, Duke University Medical Center, Durham, NC

Recorded on June 9, 2022


Kevin C. Oeffinger, MD, FASCO
Director, Duke Cancer Institute (DCI) Center for Onco-Primary Care
Director, DCI Supportive Care and Survivorship Center
Professor of Medicine, Division of Medical Oncology
Department of Medicine
Duke University Medical Center
Durham, NC

Children diagnosed with cancer are a...

Mark as Played

Gwen L. Nichols, MD, The Leukemia & Lymphoma Society, Rye Brook, NY

Recorded on May 20, 2022


Gwen L. Nichols, MD
Chief Medical Officer
The Leukemia & Lymphoma Society
Rye Brook, NY

Through the LLS Children’s Initiative, The Leukemia & Lymphoma Society (LLS) is setting out to fundamentally change how children with blood cancer are treated and cared for. For children and their families, LLS provi...

Mark as Played

Zalman Suldan, MD, PhD, Hackensack University Medical Center – Hackensack Meridian Health, Hackensack, NJ

Recorded on May 3, 2022


Zalman Suldan, MD, PhD
Attending Physician
Hackensack University Medical Center
Hackensack Meridian Health
Hackensack, NJ

The primary care physician plays an important role in the treatment of patients living with a chronic blood disorder, from early diagnosis to appropriate...

Mark as Played

Rayne H. Rouce, MD, BS, Texas Children’s Cancer Center for Cell and Gene Therapy, Houston, TX

Recorded on April 8, 2022


Rayne H. Rouce, MD, BS
Associate Professor
Department of Pediatrics
Texas Children’s Cancer Center for Cell and Gene Therapy
Baylor College of Medicine
Houston, TX

As CAR T-cell therapy continues to evolve in new and exciting ways, new indications are approved and treatment toxicitie...

Mark as Played
Francine Foss, MD and John A. Zic, MD, MMHC Recorded on March 28, 2022 This informative episode covers everything you need to know about cutaneous T-cell lymphoma, from its biology, subclassifications, targeted therapy, goals of treatment, novel toxicities, and so much more! Join Dr. Ken Miller as he delves into cutaneous T-cell lymphoma with two special guests; Dr. Francine Foss from Yale University School of Medicine and Dr. John...
Mark as Played
March 23, 2022 38 min
Srdan Verstovsek, MD, PhD, MD Anderson Cancer Center, Houston, TX Recorded on February 18, 2022 In this month’s episode, Dr. Srdan Verstovsek, from MD Anderson Cancer Center in Houston, Texas, joins us to discuss myelofibrosis. What is myelofibrosis? What is our understanding of the disease? What are the deciding factors for cells to branch off into myelofibrosis and not other myeloproliferative neoplasms? Tune in as we explore mye...
Mark as Played
Jacqueline C. Barrientos, MD, MS, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY Recorded on February 1, 2022 Shared decision making between patients and their healthcare team is an important component to treatment, regardless of the diagnosis. For chronic leukemias, patient worries may be intensified when doctors suggest forgoing active treatment for a watch-and-wait approach. In this episode, Dr. Jacqueline Barrien...
Mark as Played
Caron Jacobson, MD, Dana-Farber Cancer Institute, Boston, MA Recorded on January 4, 2022 As we move into 2022, chimeric antigen receptor (CAR) T-cell therapy continues to be a very exciting and effective treatment option for some blood cancer patients. In this episode, Dr. Caron Jacobson, Assistant Professor of Medicine, Harvard Medical School, Medical Director, Immune Effector Cell Therapy Program, Dana-Farber Cancer Institute in ...
Mark as Played
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on December 22, 2021 Each year, blood cancer professionals gather at the American Society of Hematology Annual Meeting to discuss the latest updates in blood cancer research, treatment, and clinical trials. In this episode, Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, highlights the i...
Mark as Played
John P. Leonard, MD, Weill Cornell Medicine, New York Presbyterian, New York, NY Recorded on December 16, 2021 As 2021 comes to a close, the COVID-19 pandemic continues to evolve. In this episode, Dr. John Leonard, from Weill Cornell Medicine, New York Presbyterian Hospital, discusses the latest updates on how COVID-19 affects the blood cancer patient population. What is the value of the vaccine in blood cancer patients who are on ...
Mark as Played
November 17, 2021 38 min
Maria Alma Rodriguez, MD, MACP, CMQ, The University of Texas MD Anderson Cancer Center, Houston, TX Recorded on October 21, 2021 In this episode, Dr. Maria Alma Rodriguez from The University of Texas MD Anderson Cancer Center, joins us in discussing the long-term and late effects of cancer treatment, including strategies to support survivors with physical and psychosocial effects. Dr. Rodriguez describes barriers to follow-up care,...
Mark as Played
Daniel Verina, DNP, ACNP-BC, Mount Sinai Medical Center, New York, NY Recorded on October 1, 2021 Advanced practice providers, nurses, and other members of the multidisciplinary healthcare team play an important role in treating and supporting newly diagnosed myeloma patients. In this month’s episode, Daniel Verina, DNP, ACNP-BC, Acute Care Nurse Practitioner, Multiple Myeloma Program, at the Mount Sinai Medical Center in New York,...
Mark as Played
Joshua Richter, MD, Icahn School of Medicine at Mount Sinai, New York, NY Recorded on September 10, 2021 Treating myeloma patients, especially newly diagnosed, can be very complex. How are treatment decisions determined? Who is eligible to receive a transplant? What is the patient’s role in making treatment decisions? In this month’s episode, Dr. Joshua Richter from the Icahn School of Medicine at Mount Sinai Hospital in New York, ...
Mark as Played
Lorenzo Falchi, MD and Leah Szumita, MS, RN, CCRN, ACNS-BC Recorded on August 5, 2021 Clinical trials are the foundation of advancing treatment options. Understanding their importance, dispelling myths and fears about enrollment, and acknowledging disparities in access can help providers educate their patients and discuss treatment in a clinical trial as an option at any point in the patient’s cancer journey. In this episode, we we...
Mark as Played

Popular Podcasts

    Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.

    Crime Junkie

    If you can never get enough true crime... Congratulations, you’ve found your people.

    The Piketon Massacre

    The most notorious mass murder in Ohio’s history happened on the night of April 21, 2016 in rural Pike County. Four crime scenes, thirty-two gunshot wounds, eight members of the Rhoden family left dead in their homes. Two years later a local family of four, the Wagners, are arrested and charged with the crimes. As the Wagners await four back-to-back capital murder trials, the KT Studios team revisits Pike County to examine: crime-scene forensics, upcoming legal proceedings, and the ties that bind the victims and the accused. As events unfold and new crimes are uncovered, what will it mean for all involved? What will it mean for Pike County?

    Stuff You Should Know

    If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks then look no further. Josh and Chuck have you covered.

    Morbid

    It’s a lighthearted nightmare in here, weirdos! Morbid is a true crime, creepy history and all things spooky podcast hosted by an autopsy technician and a hairstylist. Join us for a heavy dose of research with a dash of comedy thrown in for flavor.

Advertise With Us

For You

    Music, radio and podcasts, all free. Listen online or download the iHeart App.

    Connect

    © 2022 iHeartMedia, Inc.